115 related articles for article (PubMed ID: 899936)
1. Renal function in treated hypoparathyroidism. A possible direct nephrotoxic effect of vitamin D.
Parfitt AM
Adv Exp Med Biol; 1977; 81():455-64. PubMed ID: 899936
[No Abstract] [Full Text] [Related]
2. Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.
Lopes MP; Kliemann BS; Bini IB; Kulchetscki R; Borsani V; Savi L; Borba VZ; Moreira CA
Arch Endocrinol Metab; 2016; 60(6):532-536. PubMed ID: 27901178
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
Furukawa Y; Sohn H; Unakami H; Yumita S
Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D therapy in hypoparathyroidism and pseudohypoparathyroidism: weight-related dosages for initiation of therapy and maintenance therapy.
Kind HP; Handysides A; Kooh SW; Fraser D
J Pediatr; 1977 Dec; 91(6):1006-10. PubMed ID: 303694
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of progressive secondary hyperparathyroidism in advanced renal failure.
Johnson WJ; Goldsmith RS; Arnaud CD
Med Clin North Am; 1972 Jul; 56(4):961-75. PubMed ID: 4556132
[No Abstract] [Full Text] [Related]
7. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Okano K; Furukawa Y; Morii H; Fujita T
J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
[TBL] [Abstract][Full Text] [Related]
8. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
[TBL] [Abstract][Full Text] [Related]
9. Renal response to intravenous phosphate load in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Aperia A; Broberger O; Bergstrand CG; Zetterström R
Acta Paediatr Scand; 1967 Jul; 56(4):357-64. PubMed ID: 6039048
[No Abstract] [Full Text] [Related]
10. Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism.
Sinha TK; Allen DO; Queener SF; Bell NH; Larson S; McClintock R
J Lab Clin Med; 1977 Jun; 89(6):1188-97. PubMed ID: 194004
[No Abstract] [Full Text] [Related]
11. [Therapeutic application of vitamin D, its derivatives and analogues (author's transl)].
Balsan S
Ann Endocrinol (Paris); 1981; 42(4-5):492-6. PubMed ID: 6896128
[TBL] [Abstract][Full Text] [Related]
12. Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism.
Newman GH; Wade M; Hosking DJ
Eur J Clin Pharmacol; 1984; 27(1):41-6. PubMed ID: 6489426
[TBL] [Abstract][Full Text] [Related]
13. Pseudohypoparathyroidism 1942-1966. A negative progress report.
Mautalen CA; Dymling JF; Horwith M
Am J Med; 1967 Jun; 42(6):977-85. PubMed ID: 4290849
[No Abstract] [Full Text] [Related]
14. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism.
Parfitt AM
J Clin Invest; 1972 Jul; 51(7):1879-88. PubMed ID: 4338123
[TBL] [Abstract][Full Text] [Related]
15. THE RENAL CLEARANCE OF CITRATE IN MAN.
CANARY JJ; MELONI CR; CLIVE D; GROSSMAN E
Metabolism; 1964 Jan; 13():21-30. PubMed ID: 14105456
[No Abstract] [Full Text] [Related]
16. Medical treatment in primary and secondary hyperparathyroidism.
Coburn JW; Brickman AS; Massry SG
Semin Drug Treat; 1972; 2(1):117-35. PubMed ID: 4261783
[No Abstract] [Full Text] [Related]
17. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
18. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
[TBL] [Abstract][Full Text] [Related]
19. [Update on recent progress in vitamin D research. Vitamin D treatment for hypoparathyroidism.].
Minagawa M
Clin Calcium; 2017; 27(11):1623-1628. PubMed ID: 29074836
[TBL] [Abstract][Full Text] [Related]
20. Hypoparathyroidism-induced epilepsy: an overlooked cause.
Su YC; Lin YM; Hou SW; Chen CC; Chong CF; Wang TL
Am J Emerg Med; 2006 Sep; 24(5):617-8. PubMed ID: 16938604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
